Envveno Medical Corporation (NVNO)

Jan 03, 2025

Insider Buying: Francis Duhay Acquires Shares of enVVeno Medical Corp - GuruFocus.com

Jan 03, 2025

Jan 03, 2025

Envveno medical director Duhay Francis buys $249,999 in stock By Investing.com - Investing.com Canada

Jan 03, 2025

Jan 03, 2025

Envveno medical director Duhay Francis buys $249,999 in stock - Investing.com

Jan 03, 2025

Jan 02, 2025

Insider Buying: Robert Gray Acquires 3,500 Shares of enVVeno Med - GuruFocus.com

Jan 02, 2025

Jan 02, 2025

Envveno medical director Robert Gray buys $10,290 in shares - Investing.com

Jan 02, 2025

Jan 02, 2025

Envveno medical director Robert Gray buys $10,290 in shares By Investing.com - Investing.com Canada

Jan 02, 2025

Jan 02, 2025

enVVeno Medical Corporation (NASDAQ:NVNO) Director Purchases $10,290.00 in Stock - MarketBeat

Jan 02, 2025

Dec 26, 2024

enVVeno Medical Corporation (NASDAQ:NVNO) Director Acquires $15,660.00 in Stock - MarketBeat

Dec 26, 2024

Dec 26, 2024

Insider Buying: Sanjay Shrivastava Acquires Shares in enVVeno Me - GuruFocus.com

Dec 26, 2024

Dec 26, 2024

Envveno Medical's director Sanjay Shrivastava buys $15,660 in stock - Investing.com

Dec 26, 2024

Dec 23, 2024

Insider Buying: Matthew Jenusaitis Acquires 9,620 Shares of enVV - GuruFocus.com

Dec 23, 2024

Dec 23, 2024

Envveno medical director Matthew Jenusaitis buys $24,338 in stock By Investing.com - Investing.com Nigeria

Dec 23, 2024

Dec 23, 2024

Envveno medical director Matthew Jenusaitis buys $24,338 in stock - Investing.com India

Dec 23, 2024

Dec 22, 2024

Critical Survey: enVVeno Medical (NASDAQ:NVNO) versus Profound Medical (NASDAQ:PROF) - Defense World

Dec 22, 2024

Dec 20, 2024

NVNO stock touches 52-week low at $2.5 amid market challenges By Investing.com - Investing.com South Africa

Dec 20, 2024

Dec 20, 2024

NVNO stock touches 52-week low at $2.5 amid market challenges - Investing.com

Dec 20, 2024

Dec 20, 2024

Envveno Medical CEO Robert Berman acquires $30,599 in stock By Investing.com - Investing.com Australia

Dec 20, 2024

Dec 19, 2024

CEO Robert Berman Increases Stake in enVVeno Medical Corp with R - GuruFocus.com

Dec 19, 2024

Dec 19, 2024

Envveno Medical CEO Robert Berman acquires $30,599 in stock - Investing.com

Dec 19, 2024

Dec 16, 2024

enVVeno Medical completes final wave of implants in pre-clinical GLP study - TipRanks

Dec 16, 2024

Dec 16, 2024

enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe - AccessWire

Dec 16, 2024

Dec 16, 2024

enVVeno Medical Completes Key Pre-Clinical Study for Revolutionary Venous Valve, Advances FDA Approval Path - StockTitan

Dec 16, 2024

Dec 12, 2024

NVNO Stock Touches 52-Week Low at $2.9 Amid Market Challenges - Investing.com

Dec 12, 2024

Nov 27, 2024

enVVeno launches recap website highlighting VEITH Symposium participation - TipRanks

Nov 27, 2024

Nov 27, 2024

enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website - Kansas City Star

Nov 27, 2024

Nov 27, 2024

enVVeno Medical Showcases Breakthrough VenoValve Trial Data at VEITH Symposium | NVNO Stock News - StockTitan

Nov 27, 2024

Nov 27, 2024

NVNO Completes Application for VenoValve's PMA, Shares Likely to Gain - MSN

Nov 27, 2024

Nov 27, 2024

enVVeno Medical (NASDAQ:NVNO) Is In A Good Position To Deliver On Growth Plans - Simply Wall St

Nov 27, 2024

Nov 25, 2024

Reviewing enVVeno Medical (NASDAQ:NVNO) and Cerus (NASDAQ:CERS) - Defense World

Nov 25, 2024

Nov 21, 2024

PMA application submitted for VenoValve device - Venous News

Nov 21, 2024

Nov 21, 2024

enVVeno Medical (STU:5HJ) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

enVVeno Medical rises on submission of the venovalve PMA application for FDA approval - MSN

Nov 20, 2024

Nov 20, 2024

One-year data from the VenoValve US pivotal trial emerge - Venous News

Nov 20, 2024

Nov 20, 2024

enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium - AccessWire

Nov 20, 2024

Nov 20, 2024

enVVeno Medical's VenoValve Trial Shows 85% Success Rate in Pivotal Study | NVNO Stock News - StockTitan

Nov 20, 2024

Nov 19, 2024

enVVeno Medical seeks FDA approval for VenoValve - Investing.com India

Nov 19, 2024

Nov 19, 2024

enVVeno Medical seeks FDA approval for VenoValve By Investing.com - Investing.com Canada

Nov 19, 2024

Nov 19, 2024

enVVeno Medical submits VenoValve PMA application to FDA - TipRanks

Nov 19, 2024

Nov 19, 2024

enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval - AccessWire

Nov 19, 2024

Nov 19, 2024

enVVeno Medical Submits Final FDA Module for VenoValve Breakthrough Device | NVNO Stock News - StockTitan

Nov 19, 2024

Nov 19, 2024

Deep Venous Disease Treatment Devices Market 2024-2031 - openPR

Nov 19, 2024

Nov 15, 2024

Perceptive Advisors LLC's Strategic Acquisition in enVVeno Medical Corp - GuruFocus.com

Nov 15, 2024

Oct 31, 2024

enVVeno Medical (FRA:5HJ) Cyclically Adjusted FCF per Share : €0.00 (As of Jun. 2024) - GuruFocus.com

Oct 31, 2024

Oct 31, 2024

enVVeno Medical expects capital to fund company through several milestones - TipRanks

Oct 31, 2024

Oct 31, 2024

enVVeno Medical reports Q3 EPS (35c) vs. (45c) last year - TipRanks

Oct 31, 2024

Oct 31, 2024

enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year - AccessWire

Oct 31, 2024

Oct 31, 2024

EnVVeno Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 31, 2024

Oct 28, 2024

enVVeno Medical initiates six-month pre-clinical GLP study of enVVe - TipRanks

Oct 28, 2024